Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin

被引：0
|
作者：
Arrigo, Richard
Samanta, Arun
Griffith, Shanthini
Parekh, Ravish M.
Korogodsky, Maria
Rao, Kiran V.
Fisher, Adrian
Wilson, Dorian
Klein, Kenneth M.
Koneru, Baburao
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [31] Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
    Firpi, RJ
    Abdelmalek, ME
    Soldevila-Pico, C
    Reed, A
    Hemming, A
    Howard, R
    Van der Werf, W
    Lauwers, G
    Liu, C
    Crawford, JM
    Davis, GL
    Nelson, DR
    LIVER TRANSPLANTATION, 2002, 8 (11) : 1000 - 1006
  • [32] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [33] PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT FOR CHILDREN WITH HEPATITIS C
    Adiv, O. Eshach
    Zion, N.
    Shaoul, R.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E161 - E161
  • [34] Treatment of naive hepatitis C recurrence (HCV-R) in liver transplant recipients with pegylated interferon alpha-2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Schiff, E
    Tzakis, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 161
  • [35] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    HEPATOLOGY, 2002, 36 (04) : 183A - 183A
  • [36] STANDARD OR PEGYLATED INTERFERON WITH OR WITHOUT RIBAVIRIN TREATMENT OF HEPATITIS C AFTER LIVER TRANSPLANT: A META-ANALYSIS
    Papazian, Gregory K.
    HEPATOLOGY, 2008, 48 (04) : 897A - 897A
  • [37] Hepatitis C Genotype 1 Treatment Response And Outcomes Utilizing Combination Therapy With Telaprevir, Pegylated Interferon Alfa 2a And Ribavirin In Liver Transplant Recipients With Recurrent Cirrhosis
    Bhamidimarri, Kalyan R.
    Peyton, Adam
    Aye, Lydia
    Copado, Violet
    Junaidi, Omer
    Levy, Cynthia
    Martin, Paul
    Rudraraju, Madhavi
    HEPATOLOGY, 2013, 58 : 1164A - 1164A
  • [38] SYSTEMATIC REVIEW OF THE TREATMENT OF ESTABLISHED RECURRENT HEPATITIS C WITH PEGYLATED INTERFERON IN COMBINATION WITH RIBAVIRIN
    Aguilera, Victoria
    Rubin, Angel
    Benlloch, Salvador
    Zamora, Pedro A.
    Ortiz, Cecilia
    Prieto, Martin
    Berenguer, Marina
    LIVER TRANSPLANTATION, 2008, 14 (07) : S178 - S178
  • [39] A trial of pegylated interferon and ribavirin among liver transplant recipients with hepatitis C: Reasons for screening failure and low enrollment.
    Shakil, AO
    Habib, S
    Berk, B
    Eghtesad, B
    Marcos, A
    Fung, JJ
    HEPATOLOGY, 2004, 40 (04) : 360A - 360A
  • [40] Anemia is Not Predictive of Sustained Virological Response in Liver Transplant Recipients with Hepatitis C Virus Who are Treated with Pegylated Interferon and Ribavirin
    Giusto, Michela
    Rodriguez, Maria
    Navarro, Laia
    Rubin, Angel
    Aguilera, Victoria
    San-Juan, Fernando
    Ortiz, Cecilia
    Lopez-Andujar, Rafael
    Prieto, Martin
    Berenguer, Marina
    LIVER TRANSPLANTATION, 2011, 17 (11) : 1318 - 1327
12345